Lyme disease is checked through a two-step blood test that detects antibodies your immune system produces against the bacteria. But timing matters: these antibodies typically take 4 to 6 weeks to reach detectable levels after infection, so testing too early can produce a false negative. In some cases, a doctor can diagnose Lyme disease on sight, without any blood work at all.
The Rash That Doesn’t Need a Test
More than 70 percent of people with Lyme disease develop a distinctive rash called erythema migrans. It usually appears 3 to 30 days after a tick bite and expands outward over days, sometimes forming the well-known “bull’s-eye” pattern with a red ring surrounding a cleared center. But it doesn’t always look like a bull’s-eye. It can also appear as a solid red oval, a bluish-hued patch, or an expanding lesion with a crusty center.
If a doctor recognizes this rash, especially in someone who lives in or recently visited a tick-heavy area, that’s enough to start treatment. Blood tests at this stage are often negative because your body hasn’t had time to build antibodies yet. Waiting for lab confirmation when the rash is present only delays treatment.
The Two-Tier Blood Test
When there’s no rash, or when symptoms like joint pain, facial paralysis, or heart palpitations appear weeks or months after possible exposure, blood testing becomes the primary diagnostic tool. The CDC recommends a two-step process, and both steps can be run from a single blood draw.
The first step is a screening test called an enzyme immunoassay (EIA). It looks for antibodies your immune system makes in response to the Lyme bacteria. If this test comes back negative, no further testing is needed. If it’s positive or borderline, the lab runs a second, more specific test to confirm.
In the traditional version of this process, that second test is a Western blot, which identifies antibodies that react to specific proteins from the Lyme bacteria. For early-stage antibodies (IgM), the test looks for reactions to 3 specific proteins and needs at least 2 to count as positive. For later-stage antibodies (IgG), it checks 10 proteins and requires at least 5 to be positive. This two-layer approach reduces false positives, since the first screening test alone can sometimes react to antibodies from other infections.
The Newer Modified Test
Increasingly, labs are switching to a modified version of this two-tier process. Instead of using a Western blot for the second step, they run a second EIA. Both tests must be FDA-cleared to work together for this purpose.
The modified approach works in two ways. In the simpler version, both tests measure total antibodies without distinguishing early from late types. If both come back positive, the result is interpreted as consistent with Lyme infection at some point, either recent or past. In the second version, the follow-up test separates early-stage (IgM) and late-stage (IgG) antibodies, which helps narrow down whether the infection is new or older. A positive IgM with a negative IgG, for instance, points to an acute or recent infection.
The modified approach is faster to process and somewhat better at catching early infections than the traditional Western blot method.
Why Early Tests Can Be Wrong
The biggest limitation of Lyme testing is the antibody window. Your immune system needs time to recognize the bacteria and ramp up antibody production. During the first few weeks of infection, FDA-cleared tests have good sensitivity only after 4 to 6 weeks have passed. Before that, a negative result doesn’t rule out Lyme disease.
This creates a frustrating catch-22. The rash, when present, appears before antibodies are detectable. If you don’t have a rash but were bitten by a tick and feel sick within the first couple of weeks, a blood test may come back negative even if you’re infected. In these situations, doctors sometimes treat based on symptoms and exposure history, then retest later if needed.
On the other end of the timeline, antibodies can persist for months or even years after successful treatment. A positive test doesn’t necessarily mean you have an active infection right now. It means your immune system encountered the bacteria at some point.
PCR and Other Specialized Tests
In specific situations, doctors may order a PCR test, which detects the bacteria’s DNA directly rather than relying on your immune response. This is most useful for two scenarios: testing joint fluid when Lyme arthritis is suspected, and testing a skin biopsy when a rash doesn’t look like a typical Lyme rash.
PCR is not a screening tool and shouldn’t be used on people without symptoms. It’s always used alongside standard antibody testing, not as a replacement. It fills a narrow but important gap when antibody results are ambiguous and there’s tissue or fluid available to test directly.
What to Do After a Tick Bite
Not every tick bite leads to Lyme disease. The bacteria is carried primarily by blacklegged ticks (also called deer ticks), and in most cases, a tick must be attached for more than 24 hours before it can transmit the infection. If you find and remove a tick quickly, your risk drops significantly.
After removing a tick, note the date and watch for symptoms over the next 30 days. The expanding rash is the most recognizable sign, but early Lyme can also cause fever, fatigue, headache, and muscle aches that feel like the flu. If any of these appear, bring up the tick bite with your doctor. They can evaluate whether testing makes sense based on how much time has passed, where you were bitten geographically, and what symptoms you’re experiencing. If it’s been less than a few weeks, they may recommend treatment based on clinical judgment rather than waiting for a blood test that could still be negative.